» Articles » PMID: 37886027

GEMA 5.3. Spanish Guideline on the Management of Asthma

Abstract

The Spanish Guideline on the Management of Asthma, better known by its acronym in Spanish GEMA, has been available for more than 20 years. Twenty-one scientific societies or related groups both from Spain and internationally have participated in the preparation and development of the updated edition of GEMA, which in fact has been currently positioned as the reference guide on asthma in the Spanish language worldwide. Its objective is to prevent and improve the clinical situation of people with asthma by increasing the knowledge of healthcare professionals involved in their care. Its purpose is to convert scientific evidence into simple and easy-to-follow practical recommendations. Therefore, it is not a monograph that brings together all the scientific knowledge about the disease, but rather a brief document with the essentials, designed to be applied quickly in routine clinical practice. The guidelines are necessarily multidisciplinary, developed to be useful and an indispensable tool for physicians of different specialties, as well as nurses and pharmacists. Probably the most outstanding aspects of the guide are the recommendations to: establish the diagnosis of asthma using a sequential algorithm based on objective diagnostic tests; the follow-up of patients, preferably based on the strategy of achieving and maintaining control of the disease; treatment according to the level of severity of asthma, using six steps from least to greatest need of pharmaceutical drugs, and the treatment algorithm for the indication of biologics in patients with severe uncontrolled asthma based on phenotypes. And now, in addition to that, there is a novelty for easy use and follow-up through a computer application based on the chatbot-type conversational artificial intelligence (ia-GEMA).

Citing Articles

Expert opinion on gray areas in asthma management: A lesson from the innovative project "revolution in asthma" of the Italian thoracic society (AIPO-ITS).

Vaghi A, Antonelli Incalzi R, Barbaglia S, Bilo M, Bini F, Carone M Clin Transl Allergy. 2025; 15(2):e70037.

PMID: 39924642 PMC: 11807766. DOI: 10.1002/clt2.70037.


Time is lung: higher preservation of lung function in severe asthma patients after earlier mepolizumab treatment.

Gonzalez-Barcala F, Bobolea I, Dominguez-Ortega J, Banas-Conejero D, Antelo-Cea E, Martinez-Moragon E ERJ Open Res. 2025; 11(1).

PMID: 39902267 PMC: 11788806. DOI: 10.1183/23120541.00211-2024.


Protocol for the enhanced management of multimorbid patients with COPD and severe asthma: role of indoor air quality.

Gomez-Lopez A, Arismendi E, Cano I, Farre R, Figols M, Hernandez C BMJ Open Respir Res. 2025; 12(1.

PMID: 39837595 PMC: 11752068. DOI: 10.1136/bmjresp-2024-002589.


[Proposal for a future consensus on the referral of patients with severe asthma in the specialized care setting. Coordination between hospitals with and without accredited asthma units].

Carretero Gracia J, Cebollero Rivas P Open Respir Arch. 2024; 7(1):100376.

PMID: 39717140 PMC: 11664392. DOI: 10.1016/j.opresp.2024.100376.


Prognostic Factors in Severe Eosinophilic Asthma in a Pediatric Population: A Prospective Cohort Study in Spain.

Padro-Casas C, Basagana M, Martinez-Colls M, Garcia-Olive I, Pollan Guisasola C, Teniente-Serra A J Clin Med. 2024; 13(23).

PMID: 39685659 PMC: 11642421. DOI: 10.3390/jcm13237202.


References
1.
Tay T, Lee J, Radhakrishna N, Hore-Lacy F, Stirling R, Hoy R . A Structured Approach to Specialist-referred Difficult Asthma Patients Improves Control of Comorbidities and Enhances Asthma Outcomes. J Allergy Clin Immunol Pract. 2017; 5(4):956-964.e3. DOI: 10.1016/j.jaip.2016.12.030. View

2.
Boulet L, Vervloet D, Magar Y, Foster J . Adherence: the goal to control asthma. Clin Chest Med. 2012; 33(3):405-17. DOI: 10.1016/j.ccm.2012.06.002. View

3.
Brand P, Caudri D, Eber E, Gaillard E, Garcia-Marcos L, Hedlin G . Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J. 2014; 43(4):1172-7. DOI: 10.1183/09031936.00199913. View

4.
Sobieraj D, Weeda E, Nguyen E, Coleman C, White C, Lazarus S . Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis. JAMA. 2018; 319(14):1485-1496. PMC: 5876810. DOI: 10.1001/jama.2018.2769. View

5.
Taylor G, Warren S, Dwivedi S, Sommerville M, Mello L, Orevillo C . Gamma scintigraphic pulmonary deposition study of glycopyrronium/formoterol metered dose inhaler formulated using co-suspension delivery technology. Eur J Pharm Sci. 2017; 111:450-457. DOI: 10.1016/j.ejps.2017.10.026. View